Yüklüyor......

Treating Hepatic Steatosis and Fibrosis by Modulating Mitochondrial Pyruvate Metabolism

A hepatic comorbidity of metabolic syndrome, known as nonalcoholic fatty liver disease (NAFLD), is increasing in prevalence in conjunction with the pandemics of obesity and diabetes. The spectrum of NAFLD ranges from simple hepatic fat accumulation to a more severe disease termed nonalcoholic steato...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cell Mol Gastroenterol Hepatol
Asıl Yazarlar: McCommis, Kyle S., Finck, Brian N.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Elsevier 2018
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6352854/
https://ncbi.nlm.nih.gov/pubmed/30686780
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jcmgh.2018.09.017
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!